CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-20 | Liebert Debra K. Director | Purchase | +10,000 | $5.29 | $53K | 10,000 |
| 2022-10-19 | Wills Robert James Director | Purchase | +15,000 | $4.93 | $74K | 15,000 |
| 2022-10-19 | TOMSICEK MICHAEL JOHN Director | Purchase | +15,000 | $5.32 | $80K | 15,000 |
| 2022-09-14 | Liebert Debra K. Director | Other acquisition | +127 | 127 | ||
| 2022-09-07 | RTW INVESTMENTS, LP 10% owner | Purchase | +1,557,346 | $8.71 | $13.6M | 4,315,102 |
| 2022-09-07 | RTW INVESTMENTS, LP 10% owner | Sale | −1,557,346 | $8.71 | $13.6M | 4,315,102 |
| 2022-07-05 | Pasternak Richard C Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-07-05 | TOMSICEK MICHAEL JOHN Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-07-05 | Wills Robert James Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-07-05 | Giles Lisa M. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-07-05 | Liebert Debra K. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-05-31 | TRUEX PAUL F Director | Option exercise | +8,016 | $1.12 | $9K | 8,016 |
| 2022-05-31 | TRUEX PAUL F Director | Option exercise | +45,072 | $1.54 | $69K | 53,088 |
| 2022-05-31 | TRUEX PAUL F Director | Option exercise | +22,870 | $1.54 | $35K | 75,958 |
| 2022-05-31 | TRUEX PAUL F Director | Option exercise | +822 | $2.66 | $2K | 76,780 |
| 2022-05-31 | TRUEX PAUL F Director | Purchase | +5,000 | $5.60 | $28K | 81,780 |
| 2022-05-31 | TRUEX PAUL F Director | Option exercise · Stock Option (right to buy) | −8,016 | 0 | ||
| 2022-05-31 | TRUEX PAUL F Director | Option exercise · Stock Option (right to buy) | −45,072 | 0 | ||
| 2022-05-31 | TRUEX PAUL F Director | Option exercise · Stock Option (right to buy) | −22,870 | 2,659 | ||
| 2022-05-31 | TRUEX PAUL F Director | Option exercise · Stock Option (right to buy) | −822 | 117 |
Page 7 of 9 · 163 trades